UNIVERSITY OF UTAH
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-02-28
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.utah.edu
Clinical Trials
914
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (704 trials with phase data)• Click on a phase to view related trials
N-803 Maintenance Therapy Post CAR T-cell Therapy in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 13
- Registration Number
- NCT07049432
- Locations
- 🇺🇸
Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah, United States
Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.
- Conditions
- HPV-mediated Oropharyngeal Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
- First Posted Date
- 2025-07-01
- Last Posted Date
- 2025-07-01
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 42
- Registration Number
- NCT07044635
- Locations
- 🇺🇸
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
SAVE Trial: SAfe Opioid Use Video Education
- Conditions
- Breast ReconstructionBreast Cancer
- First Posted Date
- 2025-07-01
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 68
- Registration Number
- NCT07044583
- Locations
- 🇺🇸
University of Utah Huntsman Cancer Institute, Salt Lake City, Utah, United States
Serious Game to Promote Transition Readiness Skills for Patients With Congenital Heart Disease
- Conditions
- Serious GamesCongenital Heart DefectTransition-age YouthTransition to Adult CareCongenital Heart Disease in AdolescencePatient Centered Care
- First Posted Date
- 2025-06-29
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 150
- Registration Number
- NCT07042334
- Locations
- 🇺🇸
Primary Children's Hospital and University of Utah Health, Salt Lake City, Utah, United States
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
- Conditions
- Prostate CancerMetastatic Prostate CancerAndrogen Deprivation Therapy
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 74
- Registration Number
- NCT07032584
- Prev
- 1
- 2
- 3
- 4
- 5
- 183
- Next
News
Breakthrough: First Successful Stem Cell Transplant Using Deceased Donor for Blood Cancer Treatment
Huntsman Cancer Institute at the University of Utah has achieved the first-ever allogeneic stem cell transplant using cells from a deceased donor, potentially revolutionizing treatment access for blood cancer patients.
Air Pollution During Pregnancy Linked to Severe Neonatal Health Risks and Brain Development Issues
Exposure to air pollution during pregnancy, particularly in the final month, increases newborn risk of requiring intensive care treatment by up to 35%, according to recent research published in Scientific Reports.
Phase III Trial Shows Hypofractionated Radiation Therapy Safe and Effective for Breast Cancer Patients with Reconstruction
The RT CHARM phase III trial demonstrated that shortened radiation therapy (3 weeks) is noninferior to conventional 5-week treatment for breast cancer patients undergoing reconstruction after mastectomy.
Weight Loss Drugs Wegovy and Zepbound Not Cost-Effective at Current Prices, Study Finds
Popular weight loss medications semaglutide (Wegovy) and tirzepatide (Zepbound) would need significant price reductions of 82% and 30% respectively to meet standard cost-effectiveness thresholds, according to new University of Chicago research.
Cooling Therapy Shows No Benefit for Preterm Infants with Brain Injury, NIH Study Finds
A large NIH-funded clinical trial reveals that therapeutic hypothermia, previously successful in term infants, offers no protection against death or disability in preterm infants with hypoxic ischemic encephalopathy.
Higher-Dose, Two-Session Vaginal Brachytherapy Proves Effective for Endometrial Cancer Treatment
A randomized clinical trial led by Huntsman Cancer Institute demonstrates that two sessions of high-dose vaginal brachytherapy are as effective as standard multiple low-dose treatments for endometrial cancer.